Advancing Psychedelic Based Neurological Solutions

Akome is a researcher and developer of psychedelic-based pharmaceuticals for the purpose of addressing of neurological and mental health disorders with an initial focus on targeting treatments for Alzheimer’s Disease (Alzheimer’s), Parkinson’s Disease (Parkinson’s), Ischemic Stroke (Stroke), and Depression.


Sign up to our newsletter and stay up to date